$BLTE 4 SEC Filings

Filed On	Filing
05 Oct 2026	Form 4: Scholl Hendrik Peter, Chief Medical Officer Sold 500 shares ($82.7K)
09 Sep 2026	Form 4: Lin Yu-Hsin, Director Sold 74,435 shares ($14M) · Sold 26,000 shares ($5.11M)
09 Sep 2026	Form 4: Chuang Hao-Yuan, Director Sold 49,433 shares ($9.28M) · Sold 17,962 shares ($3.53M)
14 Aug 2026	Form 4: Chuang Hao-Yuan, Director Sold 367 shares ($66.2K)
14 Aug 2026	Form 4: Lin Yu-Hsin, Director Sold 365 shares ($65.8K)
22 Jun 2026	Form 4: Scholl Hendrik Peter, Chief Medical Officer Sold 10,000 shares ($1.45M)
17 Jun 2026	Form 4: Scholl Hendrik Peter, Chief Medical Officer Sold 10,000 shares ($1.41M)
08 May 2026	Form 4: Mata Nathan L., Chief Scientific Officer Sold 666 shares ($102K)
07 May 2026	Form 4: Mata Nathan L., Chief Scientific Officer Sold 1,000 shares ($154K)
06 May 2026	Form 4: Mata Nathan L., Chief Scientific Officer Sold 1,000 shares ($156K)
05 May 2026	Form 4: Mata Nathan L., Chief Scientific Officer Sold 1,000 shares ($156K)
04 May 2026	Form 4: Mata Nathan L., Chief Scientific Officer Sold 1,000 shares ($156K)
01 May 2026	Form 4: Mata Nathan L., Chief Scientific Officer Sold 1,000 shares ($157K)
30 Apr 2026	Form 4: Mata Nathan L., Chief Scientific Officer Sold 1,000 shares ($156K)
29 Apr 2026	Form 4: Mata Nathan L., Chief Scientific Officer Sold 1,000 shares ($159K)
28 Apr 2026	Form 4: Mata Nathan L., Chief Scientific Officer Sold 1,000 shares ($163K)
27 Apr 2026	Form 4: Mata Nathan L., Chief Scientific Officer Sold 1,000 shares ($160K)
24 Apr 2026	Form 4: Mata Nathan L., Chief Scientific Officer Sold 1,000 shares ($166K)
23 Apr 2026	Form 4: Lin Yu-Hsin, Director Acquired 10,000 shares (Other Transaction)
23 Apr 2026	Form 4: Scholl Hendrik Peter, Chief Medical Officer Acquired 10,000 Stock Option (right to buy) (Other Transaction)

Comments